According to the Zhitong Finance App, China Resources Pharmaceutical (03320.HK) announced the results of China Resources Pharmaceutical Holdings for the nine months ended September 30, 2026. The company achieved operating revenue of RMB 203,528 billion, an increase of 1.32% over the previous year; net profit attributable to owners of the parent company was 2,391 billion yuan, a decrease of 6.73% year on year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.